Additionally, miR-373 enhances CRC progression through the upregulation of cell cycle markers (CDK2, CDC2, and CCND2) and inflammation markers (NOS2, TGFβ1, CHI3L1, and TFPI) by induction of p-STAT3 [199]. This evidence concerns the gene TGFB1 and colorectal carcinoma.